Integrative biological studies of antitumour agents

Integrative biological studies of antitumour agents

Detalhes bibliográficos
Main Authors:	Johnson, L, Willis, A, Byrne, H, Laughton, C
Formato:	Conference item
Publicado em:	2008

Registos relacionados

An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
Por: Johnson, L, et al.
Publicado em: (2011)

A systems biology approach to the analysis of DNA-interactive antitumour agents
Por: Laughton, C, et al.
Publicado em: (2006)

The Chemistry of antitumour agents /
Por: Wilman, Derry E. V.
Publicado em: (1990)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
Por: Magda A.-A. El-Sayed, et al.
Publicado em: (2018-01-01)

An approach to the generation of simple analogues of the antitumour agent spicamycin.
Por: Mons, S, et al.
Publicado em: (2003)

Synthesis of quinazolindionyl amino acid derivatives as possible antitumour agents
Por: Ahmed Aboelmagd, et al.
Publicado em: (2017-11-01)

Synthesis of quinazolindionyl amino acid and dipeptide derivatives as possible antitumour agents
Por: A. Aboelmagd, et al.
Publicado em: (2019-07-01)

A highly cytotoxic L-rhamnose analogue of the antitumour agent spicamycin
Por: Martin, A, et al.
Publicado em: (1998)

A High-Yielding Synthesis of the Naturally Occurring Antitumour Agent Irisquinone
Por: John Butler, et al.
Publicado em: (2000-01-01)

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
Por: D Kyburz, et al.
Publicado em: (2020-02-01)

Synthesis and biological evaluation of enantiomeric rhamnose analogues of the antitumour agent spicamycin - is the mode of action by modification of N-linked glycoproteins?
Por: Martin, A, et al.
Publicado em: (1999)

Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis
Por: Ali, Abdul Manaf, et al.
Publicado em: (1996)

Biochemical mechanisms of platinum antitumour drugs /
Por: McBrien, D. C. H., et al.
Publicado em: (1986)

On the antitumour effects of B vitamins
Por: O. A. Gromova, et al.
Publicado em: (2024-02-01)

An Overview of Antitumour Activity of Polysaccharides
Por: Hongzhen Jin, et al.
Publicado em: (2022-11-01)

TIN-BASED ANTITUMOUR DRUGS
Por: Gielen, Marcel
Publicado em: (1994-05-01)

Novel disulfides with antitumour efficacy and specificity
Por: Griffiths, R, et al.
Publicado em: (2005)

Antitumour Studies of Aluminium Complexes of Synthetic Curcuminoids
Por: John, V.D., et al.
Publicado em: (2010-06-01)

Antitumour principles from alpinia galanga /
Por: Hideji Itokawa

Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma
Por: Shohei Tsuji, et al.
Publicado em: (2020-09-01)

R(h)oad to antitumour therapy
Por: Viviane Nascimento Da Conceicao, et al.
Publicado em: (2022-12-01)

Adsorption of Some Antitumour Compounds on Polymer Adsorbents
Por: M.O. Kovbuz, et al.
Publicado em: (1996-08-01)

Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
Por: Liu J, et al.
Publicado em: (2020-01-01)

Semisynthesis of Andrographolide Derivatives and Evaluation of Their Antitumour Properties
Por: Rao, Jada Srinivasa
Publicado em: (2004)

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
Por: Andrés Baeza-Morales, et al.
Publicado em: (2024-08-01)

Synthesis and antitumour activity of varitriol and its analogues
Por: Oľga Caletková, et al.
Publicado em: (2012-05-01)

Recent Advances in Functional Carbon Quantum Dots for Antitumour
Por: Cai R, et al.
Publicado em: (2021-10-01)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
Por: Katrin Kramer, et al.
Publicado em: (2019-01-01)

Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
Por: K. Umezawa, et al.
Publicado em: (2021-04-01)

A single‐domain small protein Med‐ORF10 regulates the production of antitumour agent medermycin in Streptomyces
Por: Xiaofeng Cai, et al.
Publicado em: (2021-09-01)

Chebulinic acid derived from triphala is a promising antitumour agent in human colorectal carcinoma cell lines
Por: Min Wang, et al.
Publicado em: (2018-12-01)

Impact of oncogenic pathways on evasion of antitumour immune responses
Por: Spranger, Stefani
Publicado em: (2020)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
Por: Rahel Mascha Stammer, et al.
Publicado em: (2017-01-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
Por: Emily J. Kay, et al.
Publicado em: (2023-04-01)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
Por: Piao Zhou, et al.
Publicado em: (2021-01-01)

Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment
Por: Moises A. Franco-Molina, et al.
Publicado em: (2018-07-01)

Evaluation of the purified fraction of Wilbrandia (c. f. ) verticillata for antitumour activity
Por: V. S. N. Rao, et al.
Publicado em: (1991-01-01)

Comparison of Antitumour Activities of Heated and Raw Garlic Extracts on Fibrosarcoma in Mice
Por: H Shirzad,, et al.
Publicado em: (2012-11-01)

Phenolic profile, antibacterial, antimutagenic and antitumour evaluation of Veronica urticifolia Jacq.
Por: Jelena Živković, et al.
Publicado em: (2014-07-01)

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
Por: Fens, M, et al.
Publicado em: (2008)